Joseph R II Krawczyk, the SR. VP of $MCHP, sold 4,400 shares of the company on 02-12-2026 for an estimated $345,743. We received data on the trade from a recent SEC filing. This was a sale of approximately 25.6% of their shares of this class of stock. Following this trade, they now own 12,781 shares of this class of $MCHP stock.
$MCHP Insider Trading Activity
$MCHP insiders have traded $MCHP stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $MCHP stock by insiders over the last 6 months:
- STEVE SANGHI (President, CEO and Chair of Bd) has made 0 purchases and 2 sales selling 117,323 shares for an estimated $9,425,696.
- MATHEW B BUNKER (SENIOR VP, OPERATIONS) sold 10,000 shares for an estimated $783,700
- JAMES ERIC BJORNHOLT (SENIOR VP AND CFO) has made 0 purchases and 3 sales selling 11,648 shares for an estimated $721,769.
- MATTHEW W CHAPMAN sold 10,000 shares for an estimated $682,550
- JOSEPH R II KRAWCZYK (SR. VP, WW CLIENT ENGAGEMENT) sold 4,400 shares for an estimated $345,743
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MCHP Hedge Fund Activity
We have seen 473 institutional investors add shares of $MCHP stock to their portfolio, and 664 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 8,688,217 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $553,613,187
- BARCLAYS PLC added 5,590,210 shares (+66.5%) to their portfolio in Q4 2025, for an estimated $356,208,181
- INVESCO LTD. removed 4,144,979 shares (-22.5%) from their portfolio in Q3 2025, for an estimated $266,190,551
- NORGES BANK added 3,703,281 shares (+55.1%) to their portfolio in Q4 2025, for an estimated $235,973,065
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,155,935 shares (-25.0%) from their portfolio in Q3 2025, for an estimated $202,674,145
- HOLOCENE ADVISORS, LP added 2,049,249 shares (+77.0%) to their portfolio in Q3 2025, for an estimated $131,602,770
- JANE STREET GROUP, LLC removed 2,008,270 shares (-80.9%) from their portfolio in Q4 2025, for an estimated $127,966,964
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MCHP Revenue
$MCHP had revenues of $1.2B in Q3 2026. This is an increase of 15.59% from the same period in the prior year.
You can track MCHP financials on Quiver Quantitative's MCHP stock page.
$MCHP Analyst Ratings
Wall Street analysts have issued reports on $MCHP in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026
- Piper Sandler issued a "Overweight" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
- Needham issued a "Buy" rating on 01/06/2026
- Rosenblatt issued a "Buy" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 01/06/2026
- Stifel issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for $MCHP, check out Quiver Quantitative's $MCHP forecast page.
$MCHP Price Targets
Multiple analysts have issued price targets for $MCHP recently. We have seen 17 analysts offer price targets for $MCHP in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Tom O'Malley from Barclays set a target price of $80.0 on 02/13/2026
- William Stein from Truist Securities set a target price of $69.0 on 02/11/2026
- Christopher Danely from Citigroup set a target price of $91.0 on 02/06/2026
- Matthew Prisco from Cantor Fitzgerald set a target price of $100.0 on 02/06/2026
- Harlan Sur from JP Morgan set a target price of $95.0 on 02/06/2026
- N. Quinn Bolton from Needham set a target price of $84.0 on 02/06/2026
- Kevin Cassidy from Rosenblatt set a target price of $115.0 on 02/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
